Life Science Investing Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
Life Science Investing Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors
Life Science Investing Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference
Blackrock Announces Arrangements to Address Mailing of Meeting Materials Resulting from the Canada Post Strike
